Lucid Diagnostics Inc. (LUCD) Scorecard
- 2026-Q2: Total return Lose; Revenue growth Win; EPS growth Lose.
- 2026-Q1: Total return Win; Revenue growth Win; EPS growth Lose.
- 2025-Q4: Total return Win; Revenue growth Lose; EPS growth Lose.
- 2025-Q3: Total return Lose; Revenue growth Win; EPS growth Lose.
12/120
All 120 Win/Lose results shown below
Every strict quarterly win earns 1 point. A loss, tie, or unavailable scoring value earns 0.
Trailing 1 year (4 quarters): 5 wins, 7 lossesLast fetched: 4 Sept 2026
Complete point ledger
Each cell identifies the missing side explicitly.
| Quarter | Total return | Revenue growth | EPS growth |
|---|---|---|---|
| 2026-Q21/3 |
LoseLUCD / S&P -6.96% / 15.20% |
WinLUCD / S&P 24.89% / 15.00% |
LoseLUCD / S&P LUCD unavailable / 50.40% |
| 2026-Q12/3 |
WinLUCD / S&P 5.50% / -4.33% |
WinLUCD / S&P 23.03% / 11.30% |
LoseLUCD / S&P LUCD unavailable / 27.70% |
| 2025-Q41/3 |
WinLUCD / S&P 7.92% / 2.65% |
LoseLUCD / S&P 8.28% / 9.00% |
LoseLUCD / S&P LUCD unavailable / 13.40% |
| 2025-Q31/3 |
LoseLUCD / S&P -12.17% / 8.12% |
WinLUCD / S&P 5.01% / 4.61% |
LoseLUCD / S&P -22.12% / 13.45% |
| 2025-Q21/3 |
LoseLUCD / S&P -22.82% / 10.94% |
WinLUCD / S&P 14.74% / 4.83% |
LoseLUCD / S&P -15.57% / 10.63% |
| 2025-Q12/3 |
WinLUCD / S&P 81.93% / -4.27% |
WinLUCD / S&P 39.89% / 4.98% |
LoseLUCD / S&P -6.35% / 10.57% |
| 2024-Q41/3 |
LoseLUCD / S&P 0.49% / 2.41% |
WinLUCD / S&P 79.00% / 5.25% |
LoseLUCD / S&P -15.87% / 6.15% |
| 2024-Q31/3 |
LoseLUCD / S&P -0.61% / 5.89% |
WinLUCD / S&P 179.27% / 5.89% |
LoseLUCD / S&P -19.86% / 6.11% |
| 2024-Q21/3 |
LoseLUCD / S&P 1.23% / 4.28% |
WinLUCD / S&P 379.19% / 5.38% |
LoseLUCD / S&P -16.44% / 5.12% |
| 2024-Q10/3 |
LoseLUCD / S&P -42.55% / 10.56% |
LoseLUCD / S&P LUCD unavailable / 5.71% |
LoseLUCD / S&P -21.25% / 5.59% |
| 2023-Q41/3 |
WinLUCD / S&P 20.51% / 11.69% |
LoseLUCD / S&P LUCD unavailable / 6.81% |
LoseLUCD / S&P LUCD unavailable / 7.78% |
| 2023-Q30/3 |
LoseLUCD / S&P -15.83% / -3.27% |
LoseLUCD / S&P LUCD unavailable / 7.52% |
LoseLUCD / S&P LUCD unavailable / -5.03% |
| 2023-Q20/3 |
LoseLUCD / S&P -0.71% / 8.74% |
LoseLUCD / S&P LUCD unavailable / 9.50% |
LoseLUCD / S&P LUCD unavailable / -8.57% |
| 2023-Q10/3 |
LoseLUCD / S&P 2.94% / 7.50% |
LoseLUCD / S&P LUCD unavailable / 10.77% |
LoseLUCD / S&P LUCD unavailable / -15.69% |
| 2022-Q40/3 |
LoseLUCD / S&P -11.11% / 7.56% |
LoseLUCD / S&P LUCD unavailable / 11.88% |
LoseLUCD / S&P LUCD unavailable / -17.99% |
| 2022-Q30/3 |
LoseLUCD / S&P -32.30% / -4.88% |
LoseLUCD / S&P LUCD unavailable / 13.47% |
LoseLUCD / S&P LUCD unavailable / -1.41% |
| 2022-Q20/3 |
LoseLUCD / S&P -32.74% / -16.10% |
LoseLUCD / S&P LUCD unavailable / 13.71% |
LoseLUCD / S&P LUCD unavailable / 11.04% |
| 2022-Q10/3 |
LoseLUCD / S&P -37.43% / -4.60% |
LoseLUCD / S&P LUCD unavailable / 15.97% |
LoseLUCD / S&P LUCD unavailable / 42.23% |
| 2021-Q40/3 |
LoseLUCD / S&P LUCD unavailable / 11.03% |
LoseLUCD / S&P LUCD unavailable / 15.00% |
LoseLUCD / S&P LUCD unavailable / 96.40% |
| 2021-Q30/3 |
LoseLUCD / S&P LUCD unavailable / 0.58% |
LoseLUCD / S&P LUCD unavailable / 10.77% |
LoseLUCD / S&P LUCD unavailable / 69.42% |
| 2021-Q20/3 |
LoseLUCD / S&P LUCD unavailable / 8.55% |
LoseLUCD / S&P LUCD unavailable / 6.58% |
LoseLUCD / S&P LUCD unavailable / 51.81% |
| 2021-Q10/3 |
LoseLUCD / S&P LUCD unavailable / 6.17% |
LoseLUCD / S&P LUCD unavailable / -1.06% |
LoseLUCD / S&P LUCD unavailable / 7.39% |
| 2020-Q40/3 |
LoseLUCD / S&P LUCD unavailable / 12.15% |
LoseLUCD / S&P LUCD unavailable / -3.72% |
LoseLUCD / S&P LUCD unavailable / -33.42% |
| 2020-Q30/3 |
LoseLUCD / S&P LUCD unavailable / 8.93% |
LoseLUCD / S&P LUCD unavailable / -2.04% |
LoseLUCD / S&P LUCD unavailable / -27.10% |
| 2020-Q20/3 |
LoseLUCD / S&P LUCD unavailable / 20.54% |
LoseLUCD / S&P LUCD unavailable / -0.46% |
LoseLUCD / S&P LUCD unavailable / -27.11% |
| 2020-Q10/3 |
LoseLUCD / S&P LUCD unavailable / -19.60% |
LoseLUCD / S&P LUCD unavailable / 3.47% |
LoseLUCD / S&P LUCD unavailable / -14.75% |
| 2019-Q40/3 |
LoseLUCD / S&P LUCD unavailable / 9.07% |
LoseLUCD / S&P LUCD unavailable / 5.36% |
LoseLUCD / S&P LUCD unavailable / 2.99% |
| 2019-Q30/3 |
LoseLUCD / S&P LUCD unavailable / 1.70% |
LoseLUCD / S&P LUCD unavailable / 5.02% |
LoseLUCD / S&P LUCD unavailable / 0.21% |
| 2019-Q20/3 |
LoseLUCD / S&P LUCD unavailable / 4.30% |
LoseLUCD / S&P LUCD unavailable / 6.64% |
LoseLUCD / S&P LUCD unavailable / 8.65% |
| 2019-Q10/3 |
LoseLUCD / S&P LUCD unavailable / 13.65% |
LoseLUCD / S&P LUCD unavailable / 8.12% |
LoseLUCD / S&P LUCD unavailable / 14.29% |
| 2018-Q40/3 |
LoseLUCD / S&P LUCD unavailable / -13.52% |
LoseLUCD / S&P LUCD unavailable / 9.05% |
LoseLUCD / S&P LUCD unavailable / 18.23% |
| 2018-Q30/3 |
LoseLUCD / S&P LUCD unavailable / 7.71% |
LoseLUCD / S&P LUCD unavailable / 10.21% |
LoseLUCD / S&P LUCD unavailable / 19.06% |
| 2018-Q20/3 |
LoseLUCD / S&P LUCD unavailable / 3.43% |
LoseLUCD / S&P LUCD unavailable / 9.03% |
LoseLUCD / S&P LUCD unavailable / 14.46% |
| 2018-Q10/3 |
LoseLUCD / S&P LUCD unavailable / -0.76% |
LoseLUCD / S&P LUCD unavailable / 7.68% |
LoseLUCD / S&P LUCD unavailable / 12.46% |
| 2017-Q40/3 |
LoseLUCD / S&P LUCD unavailable / 6.64% |
LoseLUCD / S&P LUCD unavailable / 7.03% |
LoseLUCD / S&P LUCD unavailable / 13.82% |
| 2017-Q30/3 |
LoseLUCD / S&P LUCD unavailable / 4.48% |
LoseLUCD / S&P LUCD unavailable / 5.68% |
LoseLUCD / S&P LUCD unavailable / 17.57% |
| 2017-Q20/3 |
LoseLUCD / S&P LUCD unavailable / 3.09% |
LoseLUCD / S&P LUCD unavailable / 4.83% |
LoseLUCD / S&P LUCD unavailable / 17.74% |
| 2017-Q10/3 |
LoseLUCD / S&P LUCD unavailable / 6.07% |
LoseLUCD / S&P LUCD unavailable / 3.67% |
LoseLUCD / S&P LUCD unavailable / 13.32% |
| 2016-Q40/3 |
LoseLUCD / S&P LUCD unavailable / 3.82% |
LoseLUCD / S&P LUCD unavailable / 2.09% |
LoseLUCD / S&P LUCD unavailable / 7.05% |
| 2016-Q30/3 |
LoseLUCD / S&P LUCD unavailable / 3.85% |
LoseLUCD / S&P LUCD unavailable / 0.20% |
LoseLUCD / S&P LUCD unavailable / -3.15% |
Dividend-reinvested, split-adjusted total return
1Y · 2025-08-29 to 2026-08-27
| Metric | LUCD total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | -21.90% | 20.78% |
| Annualized return | -21.90% | 20.78% |
5Y · 2021-10-14 to 2026-08-27
| Metric | LUCD total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | -91.63% | 83.14% |
| Annualized return | -39.11% | 12.86% |
10Y · 2021-10-14 to 2026-08-27
| Metric | LUCD total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | -91.63% | 319.30% |
| Annualized return | -21.97% | 15.41% |
Calculation rules
- window
- Latest 40 completed benchmark quarters; unavailable issuer evidence remains visible and scores 0.
- return Basis
- Issuer adjusted close reinvests distributions and normalizes splits; the S&P 500 Total Return Index is the direct benchmark.
- point Rule
- Strict same-quarter win = 1. Loss, tie or unavailable evidence = 0. No partial or subjective points.
- frequency
- Quarter endpoints only.
- fundamentals
- Trailing-four-quarter issuer revenue and EPS growth use the issuer's normalized government-filed facts.
- non Scoring
Snapshot captured 2026-09-04.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| KORU Medical Systems, Inc. (KRMD) | United States | $0.151B | -106.78 |
| Profound Medical Corp. (PROF) | $0.206B | -7.37 | |
| Neuronetics, Inc. (STIM) | United States | $0.216B | -3.25 |
| Apyx Medical Corp (APYX) | United States | $0.120B | -21.85 |
| PRO DEX INC (PDEX) | United States | $0.234B | 13.64 |
| UTAH MEDICAL PRODUCTS INC (UTMD) | United States | $0.238B | 20.93 |
| Microbot Medical Inc. (MBOT) | $0.089B | -7.97 | |
| LENSAR, Inc. (LNSR) | United States | $0.087B | 2.02 |
| InfuSystem Holdings, Inc (INFU) | United States | $0.253B | 22.52 |
| SkinHealth Systems Inc. (SKIN) | United States | $0.086B | -3.17 |